Results 1 to 10 of about 189,534 (218)
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Diagnosis and treatment of Plasmodium falciparum infections are required for effective malaria control and are pre-requisites for malaria elimination efforts; hence we need to monitor emergence, evolution and spread of drug- and diagnostics-resistant ...
A. Fola +15 more
semanticscholar +1 more source
Artemisinin resistance (delayed P. falciparum clearance following artemisinin-based combination therapy), is widespread across Southeast Asia but to date has not been reported in Africa1–4. Here we genotyped the P.
A. Uwimana +17 more
semanticscholar +1 more source
Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria.
Understanding and controlling the spread of antimalarial resistance, particularly to artemisinin and its partner drugs, is a top priority. Plasmodium falciparum parasites resistant to chloroquine, amodiaquine, or piperaquine harbor mutations in the P ...
Kathryn J. Wicht, Sachel Mok, D. Fidock
semanticscholar +1 more source
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Since the year 2000, a concerted campaign against malaria has led to unprecedented levels of intervention coverage across sub-Saharan Africa. Understanding the effect of this control effort is vital to inform future control planning.
S. Bhatt +31 more
semanticscholar +1 more source
Structure and Drug Resistance of the Plasmodium falciparum Transporter PfCRT
The emergence and spread of drug-resistant Plasmodium falciparum impedes global efforts to control and eliminate malaria. For decades, treatment of malaria has relied on chloroquine (CQ), a safe and affordable 4-aminoquinoline that was highly effective ...
Jonathan Kim +17 more
semanticscholar +1 more source
Major subpopulations of Plasmodium falciparum in sub-Saharan Africa
Ebb and flow of parasite populations The population genetics of the malaria parasite Plasmodium falciparum across Africa is poorly understood but important to know for grasping the risks and dynamics of the spread of drug resistance. Harnessing the power
A. Amambua-Ngwa +20 more
semanticscholar +1 more source
A reduction in the global burden of malaria over the past two decades has encouraged efforts for regional malaria elimination. Despite the need to target all Plasmodium species, current focus is mainly directed towards Plasmodium falciparum, and to a ...
Victor Yman +12 more
semanticscholar +1 more source
The widely used antimalarial combination therapy dihydroartemisinin + piperaquine (DHA + PPQ) has failed in Cambodia. Here, we perform a genomic analysis that reveals a rapid increase in the prevalence of novel mutations in the Plasmodium falciparum ...
Leila S Ross +11 more
semanticscholar +1 more source
Malaria, a mosquito‐borne infectious disease caused by parasites of the genus Plasmodium continues to be a major health problem worldwide. The unicellular Plasmodium‐parasites have the unique capacity to infect and replicate within host erythrocytes.
Anja T. R. Jensen +2 more
semanticscholar +1 more source
Pantothenamides form antimetabolites that interfere with acetyl-CoA metabolism in the human malaria parasite Plasmodium falciparum. Development of a new antimalarial drug Pantothenenic acid, or vitamin B5, is an essential nutrient for the deadly malaria ...
J. Schalkwijk +30 more
semanticscholar +1 more source

